| HS Code | 690976 |
| Product Name | HiberCell HC-5404 |
| Alternative Name | PERK inhibitor |
| Mechanism Of Action | Inhibits protein kinase R-like endoplasmic reticulum kinase (PERK) |
| Target | PERK (EIF2AK3) |
| Therapeutic Area | Oncology |
| Molecular Formula | C22H18Cl2N4O3S |
| Molecular Weight | 505.4 g/mol |
| Clinical Phase | Phase 1/2 |
| Company | HiberCell |
| Intended Application | Treatment of solid tumors |
| Cas Number | 2221778-28-9 |
| Route Of Administration | Oral |
| Storage Conditions | Store at -20°C |
| Activity | Selective PERK inhibitor |
| Synonyms | HC-5404, HC-5404-FS |
As an accredited HiberCell HC-5404 (PERK inhibitor) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | HiberCell HC-5404 (PERK inhibitor), 10 mg, supplied in a labeled amber glass vial with tamper-evident seal, stored refrigerated. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for HiberCell HC-5404 (PERK inhibitor): Securely packed, temperature-controlled, 20-foot container for safe international chemical transport. |
| Shipping | **HiberCell HC-5404 (PERK inhibitor)** is shipped in compliance with all relevant regulations for research chemicals. It is packaged securely in temperature-controlled, insulated containers to maintain stability and prevent degradation. The container includes appropriate labeling and safety documentation. Expedited shipping is used to ensure prompt delivery and compound integrity. |
| Storage | HiberCell HC-5404 (PERK inhibitor) should be stored according to standard practices for sensitive small-molecule inhibitors. Store the compound at -20°C, protected from light and moisture. Keep the container tightly closed and in a dry, well-ventilated area. Avoid repeated freeze-thaw cycles, and always consult the manufacturer’s data sheet for any specific storage instructions for optimal stability. |
| Shelf Life | HiberCell HC-5404 (PERK inhibitor) typically has a shelf life of 2 years when stored at -20°C, protected from light. |
HiberCell HC-5404, a specific inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK), is manufactured for integration across advanced pharmaceutical and life science production environments. Our material supports stringent downstream requirements, addressing critical control points in targeted therapeutics development, diagnostic reagent processing, and preclinical research-grade reagent formulation.
Pharmaceutical manufacturers utilize this PERK inhibitor during compound screening and optimization phases for oncology therapeutics. The compound integrates into the hit-to-lead and lead optimization pipeline, modulating the cellular unfolded protein response (UPR) pathway. Downstream, researchers deploy this material to profile kinase selectivity and to investigate UPR regulation in cancer cell viability assays, enabling precise adjustment of candidate molecules for tumor microenvironment targeting and resistance mechanism studies.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Contract research and biotech producers apply the inhibitor in cell stress pathway modulation assays and for establishing dose-response curves during stable cell line engineering. Integration commonly occurs during screening for endoplasmic reticulum stress resilience and for UPR modulation in high-throughput imaging platforms, underpinning the development of engineered cell models leveraged in pharmaceutical R&D.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
IVD and laboratory diagnostic device producers include this raw material in the formulation of quality control reagents and positive control wells for unfolded protein response assays. The inhibitor is integral to the generation of reference controls for ELISA and Western blot kits targeting ER stress biomarkers, allowing manufacturers to benchmark assay sensitivity and specificity to UPR pathway perturbation.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Producers of specialty biochemical reagents formulate the PERK inhibitor into catalog tools for academic and pharmaceutical preclinical research, supporting translational studies on stress response pathways. As a critical modulator for mechanistic research, the compound is offered in both standardized and custom packaging, ensuring traceability and reproducibility across diverse model systems.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Competitive HiberCell HC-5404 (PERK inhibitor) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618018036652 or mail to sales6@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8618018036652
Email: sales6@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
At our labs, the focus has always been on turning complex chemistry into solutions the research community can trust. The day we brought HiberCell HC-5404 (PERK inhibitor) online was no exception. There’s a lot of talk these days about targeting the endoplasmic reticulum (ER) stress response, but we have noticed a gap in offerings for tools that actually handle the specificity and reproducibility required for rigorous studies. We built HC-5404 to address those gaps, drawing on two decades of direct bench and pilot scale experience with kinase modulators. Watching compounds go from beaker to bottle under our own roofs gives us a perspective that “off-the-shelf” partners simply don’t have.
HC-5404 is our answer to the contemporary needs of academic groups, oncology startups, and translational programs interested in the protein kinase R-like endoplasmic reticulum kinase (PERK) pathway. Every batch comes off the reactor with stringent QC, fulfilling purity above 98%, and full NMR and mass spectrometry data can be supplied on request without hesitation. Solubility matters to biologists and chemists alike—a lot of commercially available inhibitors either clump or degrade by the time they reach a microplate. We’ve engineered our formulation for reliable solubility in common DMSO concentrations and PBS, so loss of compound activity isn’t a factor during assay setup. Our group doesn’t cut corners on packaging integrity, knowing what a surprise humidity spike can do during shipping. We fill, seal, and label in a temperature-controlled suite that matches the handling standards used by major clinical trial centrals.
HC-5404 is not just another inhibitor on a price sheet. It targets the PERK signaling pathway, which has drawn attention for its part in cellular stress responses—contributing not only to tumor biology, but also to neurodegeneration, metabolic disorders, and chronic inflammation. Research teams using HC-5404 have told us about their efforts to unravel mechanisms behind drug resistance in cancer cell lines and to probe how stressed microenvironments lead to immune evasion. Our familiarity with upstream kinase inhibition—going back to early JAK/STAT modulator syntheses—helped us tune HC-5404 for optimal ENZ50 values and lack of off-target activity in typical screens. Several studies, including two multicenter collaborations in the last year, utilized our product to dissect downstream phosphorylation events and unfolded protein response (UPR) markers in cell-based models.
The market sits crowded with products from generic sources, but as the manufacturers, we see under the hood. A number of PERK inhibitors from bulk suppliers fail identity or stability tests. With HC-5404, the difference is clarity—customers call us directly with questions and requests, and we can deliver synthesis records, batch histories, and impurity profiles. Our QC labs don’t just confirm purity; we log storage conditions for every shipment, ensuring consistency even with scale-up. This is the real-world advantage when you run and own the reactors. R&D teams working on tight timelines tell us they trust our lots batch after batch, citing reproducibility in dose-response studies and pharmacokinetics. Because we don’t ship relabeled products from outside vendors, we hold ourselves personally responsible for integrity at every stage. Several customers have checked the spectral profile themselves—they never find discrepancies or slip-ups of the kind that happen with resellers or drop-shippers.
Every container of HC-5404 reflects direct input from process engineers, formulation chemists, and bench scientists who specialize in biotarget validation. We use high-resolution preparative chromatography to exclude even minor side-products, and our analytical staff run orthogonal methods to cross-confirm each batch—a crucial step for pharmacology programs that can’t afford trial-killing variability. We know how real supply risks bite a program: delays, inconsistencies, or failures in chemical quality undermine grant milestones and delay publications. Since we oversee all operations in-house, from synthesis up through packaging, partners in top-tier medical schools have praised the “hand-in-glove” fit between their protocol needs and the materials we deliver. Our history of custom analog development means HC-5404 stands as a foundation for future modifications—if a new derivative or salt form becomes research-relevant, our pilot reactors and kilo labs are ready to adapt.
We keep our finger on the pulse of current trends. PERK inhibition isn’t a lone-wolf strategy; it’s part of a bigger question in cell biology and pathophysiology. Our earliest adopters used HC-5404 to examine not just cancer, but also the role of ER stress in pancreatic β-cell function and atherosclerosis models. Several industry labs reached out after early-phase results suggested HC-5404 enabled sharper readouts in gene expression and proteomics workflows, especially in previously intractable systems. Investigators working at the interface of immunology and oncology have told us their confidence in the product increased as they saw their data hold up across repeated runs. This is what careful chemistry and attention to user feedback delivers—instruments, pipettes, and sequencing platforms can only perform at their best when the underlying reagents keep to high standards.
Anyone who has scaled up a chemical program knows the headaches involved. Small-batch laboratory syntheses often give way to completely different impurity profiles and physical characteristics when a project goes into pilot scale or production grade. As the ones actually holding the raw materials, running the distillations, and crystallizing product, we control the process end-to-end. Our intermediates are tracked and tested at every step, not just at final release, minimizing the odds of “surprise” artifacts or batch drift. Some labs come to us after burning through cell lines or animals with inconsistent material from other sources. We walk them through our record-keeping, from solvent choices straight through to final lyophilization. For customers in regulated environments, GxP-like handling means documentation is always available, not cobbled together post hoc. The upshot is easy—predictable output for both high-throughput assays and detailed mechanistic cell studies, without having to call in backup orders at the last moment.
We don’t see chemistry as a strictly “in-box” business. Problems crop up fast, especially in targets that intersect with cell stress pathways. The PERK pathway interacts with other UPR nodes and can easily trigger off-target effects if the inhibitor is not genuinely selective. Our synthesis teams designed the core of HC-5404 with this practical challenge in mind. While at some companies, troubleshooting off-target toxicity gets handed off to a support desk, in our shop any issue sparks a lab meeting. Our commitment: if a client sees a hiccup in downstream markers such as eIF2α phosphorylation or CHOP expression, we run in-house controls on their batch and look for solutions with our collaborators. This approach increases confidence not just for repeat customers but also for program managers who need robust, actionable data for regulatory or grant reporting.
We take an active view of partnerships. Some of our collaborators have used HC-5404 for dozens of independent studies. Each time, they rely on us not just for product supply but for advice, troubleshooting, and technical know-how. We often supply reference standards alongside HC-5404, so scientists can double-check their instrument calibration and run side-by-side assays to verify their protocols. Our technical leaders run internal method development studies, pressure-testing cheminformatics, TLC, and chromatography results before green-lighting new lots. Working with the product in house means we know its quirks and strengths through hands-on application, and our customer support doesn’t end after the invoice goes out—scientists talk directly with the same chemists who formulated their compounds and developed synthetic routes.
Advances in fields like oncology and neurology do not come from the comfort zone. Often, we receive questions from research groups about using HC-5404 in challenging or novel models, such as patient-derived xenografts or single-cell transcriptomics. Because we oversee every gram that leaves our warehouse, we’re uniquely positioned to help troubleshoot, suggest protocol tweaks, or, if requested, supply alternate formulations. Our support stems from real bench experience and ongoing communication with all kinds of users—from major teaching hospitals to startup labs just building out their assay platforms. In cases where custom dosing or stabilization is needed, our chemists collaborate actively with clients rather than passing the buck to resellers or outside agents. We understand that for truly exploratory work, waiting on third parties or overseas sourcing introduces friction that can break a project’s momentum. Our lab-to-bench approach builds loyalty with research teams tackling questions from ER stress-related apoptosis to adaptive resistance in aggressive disease models.
In today’s market, it's easy to lose sight of the chain between molecule design and end-use research. At our plant, even the small technical wins matter—how powders pack down, how product behaves when dissolved, what degradation products emerge in long-term storage. Because we analyze and refine the entire process, from raw material procurement through to storage recommendations, we avoid guesswork that plagues many non-manufacturer distributors. Conducting our own stability and forced degradation studies means the shelf-life and transport protocols we recommend are grounded in firsthand observation, not speculation or vendor promises.
Researchers in academia and industry alike are pushing for higher standards of reproducibility and open data sharing. Our model in making HC-5404 readily available, along with access to batch and QC data, gives research teams the tools they need for repeatable and transparent experimentation. We don’t claim to solve the reproducibility crisis, but we back up our product with documentation and method details, not just a product number. Open conversations with our users drive ongoing improvements. Recent collaborations with precision medicine groups and computational modelers highlighted ways we could optimize batch records for shared platforms. The feedback loop between our chemists and field researchers ensures that the improvements are meaningful and relevant to those doing the hands-on science.
It feels rewarding to know that our work—packaging out a compound like HC-5404 to individual research groups—has an immediate impact. Some teams pursue basic mechanisms underlying ER stress and its interaction with autophagy or apoptosis; others need reliable tools for rigorous pharmacological profiling before moving to in vivo models. As the only ones responsible for the product’s full lifespan, we’ve built a steady flow of feedback and innovation. No step of HC-5404’s journey, from planning to post-delivery follow-up, happens without experienced eyes on it. The pride in a high-quality molecule stands alongside our commitment to supporting emerging science, fielding technical questions ourselves, and constantly refining what we ship and how we support scientists.
We haven’t stopped at initial process validation. As fresh applications of PERK inhibitors surface—from studies on metabolic disorders to investigations into neurodegenerative pathways—our R&D and process teams continue to fine-tune every stage. By openly sharing stability data, application notes, and lot-specific analytics, we ensure researchers are equipped with the most reliable reagents possible. It’s not just about selling a vial; it’s about sustaining trust over years and earning our role as a real manufacturing partner. Our in-house quality program tracks both major and minor changes, giving customers a level of traceability and transparency that’s rare even in top-tier chemical supply.
The advantage of manufacturing HC-5404 ourselves means lab scientists don’t face supply chain mysteries, uncertain provenance, or rebranded intermediates. Quality, reliability, and technical insight come standard, and we pass on practical benefits—such as custom aliquoting and tailored consultation—without margin added by middlemen. Our users receive not just what’s listed on a data sheet, but ongoing support and troubleshooting from the people who understand the chemistry down to its origins.
HC-5404 means more to us than a line in a catalog. It serves as the outcome of years of hands-on work and ongoing conversations with forward-thinking research teams. Every shipment reflects our direct commitment to product integrity and to meaningful relationships with the researchers pursing new discoveries. We watch HC-5404 deliver consistent results in both high-throughput screens and targeted mechanistic studies—facing every challenge not as a detached supplier, but as a partner at the bench. As a true manufacturer, we keep improving, keep listening, and keep building on a foundation of trusted chemical supply that advances scientific progress step by step.